SCHEMBL24252718

SCHEMBL24252718

c1ccc(-c2c3ccccc3c(-c3ccccc3)c3cc(-c4nc(-c5ccc(-c6cccnc6)cc5)cc(-c5ccc(-c6cccnc6)cc5)n4)ccc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.53
CYP19A1 P11511 2/20 0.51
CYP11B1 P15538 2/20 0.44
CYP17A1 P05093 1/20 0.44
CYP11B2 P19099 1/20 0.44
MKNK1 Q9BUB5 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
ALDH1A1 P00352 8/20 0.43
MAPT P10636 4/20 0.43
KDM4E B2RXH2 4/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 5/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
CYP1A2 P05177 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19168541 0.96 DHODH (0.52) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL22763782 0.93 DHODH (0.56) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL17369027 0.93 DHODH (0.56) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL17013859 0.92 DHODH (0.53) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL17369026 0.92 DHODH (0.53) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL24252236 0.92 DHODH (0.53) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL17013980 0.91 DHODH (0.55) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL24252243 0.90 DHODH (0.56) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL30857462 0.90 DHODH (0.56) DHODHCYP19A1CYP11B1CYP17A1CYP11B2
SCHEMBL19172132 0.90 DHODH (0.56) DHODHCYP19A1CYP11B1CYP17A1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220052268-A1 COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220052268-A1 COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC29A1, NUDT1, SLC29A2 DHODH 202/4885CYP19A1 2810/4885CYP11B1 4052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.